Shell Asset Management’s MiMedx Group MDXG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$28K Sell
4,015
-7,241
-64% -$50.3K ﹤0.01% 989
2025
Q2
$69K Sell
11,256
-1,242
-10% -$8.26K ﹤0.01% 1083
2025
Q1
$95K Sell
12,498
-543
-4% -$4.54K ﹤0.01% 1026
2024
Q4
$125K Hold
13,041
0.01% 993
2024
Q3
$77K Buy
+13,041
New +$86.4K ﹤0.01% 1106
2024
Q1
$96K Buy
+13,784
New +$111K ﹤0.01% 1034
2019
Q1
Sell
-29,899
Closed -$54K 1209
2018
Q4
$54K Sell
29,899
-2,500
-8% -$13.9K ﹤0.01% 1112
2018
Q3
$200K Hold
32,399
﹤0.01% 1100
2018
Q2
$207K Sell
32,399
-1,800
-5% -$12.8K ﹤0.01% 1052
2018
Q1
$238K Hold
34,199
﹤0.01% 1039
2017
Q4
$431K Hold
34,199
0.01% 948
2017
Q3
$406K Buy
+34,199
New +$507K 0.01% 924

Other funds holding MDXG

Shell Asset Management's MDXG Position: Q3 2025 in Review

Shell Asset Management reduced its MiMedx Group (MDXG) stake by 64% in Q3 2025, selling an estimated $50.3K and leaving 4,015 shares worth $28K. The position accounts for ﹤0.01% of the portfolio, ranked #989.

Shell Asset Management first reported a position in MDXG in Q3 2017 and has held it in 12 quarters since. The position peaked at $431K in Q4 2017. 231 funds tracked by Wall St. Rank hold MDXG as of Q3 2025.

  • Shell Asset Management held 4,015 shares of MiMedx Group worth $28K as of Q3 2025.
  • Shell Asset Management sold 7,241 MiMedx Group shares in Q3 2025, an estimated $50.3K.
  • MiMedx Group made up ﹤0.01% of Shell Asset Management's portfolio in Q3 2025, its #989 holding.
  • Shell Asset Management first reported a position in MiMedx Group in Q3 2017 and has held it in 12 quarters since.
  • Shell Asset Management's MiMedx Group position peaked at $431K in Q4 2017.
  • 231 funds tracked by Wall St. Rank held MiMedx Group as of Q3 2025.

Based on Shell Asset Management's 13F filing for Q3 2025, filed 7 Nov 2025.